Stauber Named U.S. Representative of Relora™

Stauber Named U.S. Representative of Relora™

FULLERTON, Calif.--Stauber Performance Ingredients Inc. was named the U.S. marketing representative of Relora™, a patent-pending stress relief ingredient from Next Pharmaceuticals in Irvine, Calif. Relora is a proprietary blend of plant extracts from two botanicals (Magnolia officinalis and Phellodendron amurense) used in Traditional Chinese Medicine.

"We are very excited about this opportunity to introduce Relora, a safe and effective ingredient that has not only been proven to relieve stress, but has also been shown to significantly decrease cortisol and increase DHEA in stressed individuals," said Dan Stauber, chief executive officer of Stauber (www.stauberusa.com). Next Pharmaceuticals has conducted animal and human trials on the ingredient to support its safety and efficacy, including one recent study that found Relora decreased cortisol levels by 28 percent in stressed individuals.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines